Cheng Lulu, Fang Zezheng, Wang Junpeng, Xi Kaiyan, Zhang Yi, Feng Fan, Yu Le, Santiago Myla, Wang Jingjing, Wu Zimei, Wang Kang-Nan, Daubon Thomas, Ni Shilei, Zhang Yanrong, Zhang Yulin
College of Chemistry & Pharmacy, Northwest A&F University, Shaanxi, Yangling, PR China.
Department of Neurosurgery, Shandong Key Laboratory of Brain Health and Function Remodeling, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.
Nat Commun. 2025 Jul 28;16(1):6946. doi: 10.1038/s41467-025-62244-5.
Cellular and molecular heterogeneity contributes to the insufficient immunogenicity of glioblastoma multiforme (GBM), a lethal malignancy characterized by post-resection relapse, ultimately leading to limited immune cell infiltration. Here, we report a strategy to boost tumor immunity by activating the endogenous cGAS-STING signaling pathway through in-situ manipulation of the mitochondrial electron transport chain (ETC), thereby augmenting the immune responsiveness of GBM. Under white light irradiation, the synthetic butterfly-shaped photosensitizer B-TTPy disrupts the mitochondrial ETC by producing excessive reactive oxygen species. Synergistically, inhibition of checkpoint kinase 1 amplifies ETC dysfunction, thus enhancing the cytotoxicity of B-TTPy against tumor cells. Our results demonstrate that the in-house-customized Mitochondrial Electron Alteration Nanoparticles in Glioblastoma (MEANING) efficiently activate innate and adaptive immune response by recruiting antigen-presenting cells and cytotoxic T cells to the surgical margin. Moreover, biodegradable hydrogel-medicated surgical cavity treatment with MEANING can reshape the immunosuppressive tumor microenvironment and eliminate residual GBM cells. In sum, our findings establish a local immune activation approach for GBM, to prevent postoperative tumor recurrence and identify ETC blockade as a promising therapeutic strategy for low-immunogenic tumors.
细胞和分子异质性导致多形性胶质母细胞瘤(GBM)免疫原性不足,GBM是一种致命的恶性肿瘤,其特征是切除后复发,最终导致免疫细胞浸润受限。在此,我们报告一种通过原位操纵线粒体电子传递链(ETC)激活内源性cGAS-STING信号通路来增强肿瘤免疫的策略,从而增强GBM的免疫反应性。在白光照射下,合成的蝴蝶形光敏剂B-TTPy通过产生过量的活性氧破坏线粒体ETC。协同地,抑制检查点激酶1会放大ETC功能障碍,从而增强B-TTPy对肿瘤细胞的细胞毒性。我们的结果表明,内部定制的胶质母细胞瘤线粒体电子改变纳米颗粒(MEANING)通过将抗原呈递细胞和细胞毒性T细胞募集到手术边缘,有效地激活先天和适应性免疫反应。此外,用MEANING进行可生物降解水凝胶介导的手术腔治疗可以重塑免疫抑制性肿瘤微环境并消除残留的GBM细胞。总之,我们的研究结果建立了一种针对GBM的局部免疫激活方法,以防止术后肿瘤复发,并确定ETC阻断是低免疫原性肿瘤的一种有前景的治疗策略。
Cancer Commun (Lond). 2025-3-14
CNS Neurosci Ther. 2024-7
J Immunother Cancer. 2025-6-22
Extracell Vesicles Circ Nucl Acids. 2023-5-23
Nat Chem Biol. 2024-10
Science. 2023-9-22
Trends Cancer. 2023-9
Signal Transduct Target Ther. 2023-7-19